Search
Search results for: adma
-
Organometallic block copolymers as catalyst precursors for templated carbon nanotube growth.
PublicationArtykuł przedstawia zastosowanie organometalicznych kopolimerów blokowych jako prekursorów katalizatorów dla syntezy nanorurek węglowych. Zjawisko mikroseparacji fazowej kopolimerów blokowych zostało wykorzystane dla przygotowania matrycy aktywnych katalitycznie domen o rozmiarach ~20 nm. Domeny zawierające poli(ferrocenylosilan) (PFS) po utlenienu w plazmie tlenowej oraz redukcji z Fe(III) do Fe(II) oraz Fe(0) z powodzeniem katalizują...
-
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets
PublicationNitric oxide (NO) is one of the most important molecules released by endothelial cells, and its antiatherogenic properties support cardiovascular homeostasis. Diminished NO bioavailability is a common hallmark of endothelial dysfunction underlying the patho‑ genesis of the cardiovascular disease. Vascular NO is synthesized by endothelial nitric oxide synthase (eNOS) from the substrate L‑arginine (L‑Arg), with tetrahydrobiopterin...
-
A pilot study with flow mediated skin fluorescence: A novel device to assess microvascular endothelial function in coronary artery disease
PublicationBackground: Endothelial dysfunction is one of the earliest vascular manifestations in the pathogenesis of cardiovascular disease. Noninvasive, simple and inexpensive methods of endothelial function assessment are therefore needed. Methods: Microvascular endothelial function was assessed in coronary artery disease (CAD) patients by flow mediated skin fluorescence (FMSF), based on measurements of NADH fluorescence intensity during...
-
Endothelial Dysfunction Driven by Hypoxia—The Influence of Oxygen Deficiency on NO Bioavailability
PublicationCardiovascular diseases (CVDs) are the leading cause of death worldwide. The initial stage of CVDs is characterized by endothelial dysfunction, defined as the limited bioavailability of nitric oxide (NO). Thus, any factors that interfere with the synthesis or metabolism of NO in endothelial cells are involved in CVD pathogenesis. It is well established that hypoxia is both the triggering factor as well as the accompanying factor...